The pharmaceutical world is witnessing a significant shift in glucose treatment with the emergence of GLP-1 transdermal devices. These systems offer a potentially more comfortable alternative to subcutaneous administrations of GLP-1 receptor agonists, lessening the requirement of daily needle pricks. The technology administers the medication dir… Read More